Delivery Order SPE2DB20D3104-SPE2DB25FV9N6
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $62,597.51 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract is scheduled for completion by August 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a relatively small transaction within AmerisourceBergen's broader federal...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 25, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract is valued at $79,539.38 and operates under a firm fixed-price structure with an ultimate completion date of September 26, 2025. This non-competitive, non-set-aside delivery order will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, by the Defense Logistics Agency (DLA) for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $12,635.27, is set to be completed by August 13, 2025, and represents performance at the company's Conshohocken facility. The contract was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $134,559.71 on August 13, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 14, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,117.08 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 7, 2025, by the Defense Logistics Agency for $50,225.55 to supply Biktarvy 50-200-25 mg tablets in quantities of 30. This firm fixed-price delivery order, which is not set-aside designated, is expected to be completed by August 8, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a continuation of...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $25.8K delivery order on August 20, 2025, for Biktarvy 50-200-25 mg tablets (30-count units), with completion scheduled for August 21, 2025. This competitive, non-set-aside award was issued under firm fixed pricing terms and represents a single delivery order transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- AmerisourceBergen Drug Corp was awarded a delivery order for Biktarvy 50-200-25 mg tablets (30-count units) valued at $57,435.30 by the Defense Logistics Agency on September 24, 2025, with a completion date of September 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $102,913.01 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The contract carries no set-aside designation, reflecting open competition for this pharmaceutical supply requirement. Performance will be executed from...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $23,291.64 on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price contract covers the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The award utilized open competitive procurement with no set-aside designation, reflecting the vendor's capability to meet federal...